Paper23134
Assessment of combined oral theophylline and inhaled beta-adrenoceptor agonist bronchodilator therapy.
Marlin GE and 3 others. Br J Clin Pharmacol, 1978. Cited by 39 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Assessment of combined oral theophylline and inhaled beta-adrenoceptor agonist bronchodilator therapy. Papers, record 23134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23134
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Airway Obstruction | Major topic |
| Bronchodilator Agents | Major topic |
| Catechols | Major topic |
| Piperidines | Major topic |
| Theophylline | Major topic |
| Administration, Oral | |
| Adult | |
| Aerosols | |
| Aged | |
| Chronic Disease | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Drug Evaluation | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,940 | Comparison of the beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man. | Br J Clin Pharmacol | 1975 | https://conductscience.org/library/papers/10940 | PubMed |
| 2 | 1,116,382 | Comparison between the bronchodilator and cardiovascular effects of inhaling 0.5 mg. rimiterol ('Pulmadil') and 0.2 mg. salbutamol. | Curr Med Res Opin | 1975 | https://conductscience.org/library/papers/1116382 | PubMed |
| 3 | 1,233,207 | Plasma level and broncholytic effect of choline theophyllinate after a single dose of a press-coated tablet formulation. | Eur J Clin Pharmacol | 1975 | https://conductscience.org/library/papers/1233207 | PubMed |
| 6 | 13,716,795 | The response to bronchodilators in intrinsic asthma. | Q J Med | 1961 | https://conductscience.org/library/papers/13716795 | PubMed |
| 7 | 14,058,168 | PATTERNS OF RESPONSE TO BRONCHODILATOR IN YOUNG PATIENTS WITH ASTHMA. | Australas Ann Med | 1963 | https://conductscience.org/library/papers/14058168 | PubMed |
| 8 | 14,114,639 | CLINICAL EVALUATION OF ELIXOPHYLLIN WITH CORRELATION OF PULMONARY FUNCTION STUDIES AND THEOPHYLLINE SERUM LEVELS IN ACUTE AND CHRONIC ASTHMATIC PATIENTS. | Dis Chest | 1964 | https://conductscience.org/library/papers/14114639 | PubMed |
| 9 | 170,700 | Bronchodilator drug efficacy via cyclic AMP. | Thorax | 1975 | https://conductscience.org/library/papers/170700 | PubMed |
| 10 | 240,780 | The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients. | Int J Clin Pharmacol Biopharm | 1975 | https://conductscience.org/library/papers/240780 | PubMed |
| 11 | 4,108,129 | Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. II. Influence of cellular levels of cyclic AMP. | Fed Proc | 1971 | https://conductscience.org/library/papers/4108129 | PubMed |
| 12 | 4,147,213 | Clinical assessment of bronchodilator drugs delivered by aerosol. | Thorax | 1973 | https://conductscience.org/library/papers/4147213 | PubMed |
| 13 | 4,401,704 | A comparison of isoprenaline, salbutamol, and rimiterol inhalation on skin temperature, heart rate, and respiration in man. | J Clin Pharmacol New Drugs | 1972 | https://conductscience.org/library/papers/4401704 | PubMed |
| 14 | 4,404,808 | The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease. | Scand J Respir Dis | 1972 | https://conductscience.org/library/papers/4404808 | PubMed |
| 15 | 4,412,772 | Determination of theophylline and its metabolites in human urine and serum by high-pressure liquid chromatography. | J Lab Clin Med | 1974 | https://conductscience.org/library/papers/4412772 | PubMed |
| 16 | 4,598,678 | Clinical trial of rapidly dissolving theophylline tablets. | Med J Aust | 1974 | https://conductscience.org/library/papers/4598678 | PubMed |
| 17 | 4,932,744 | Preliminary studies of a new bronchodilator (WG 253) in man. | J Clin Pharmacol New Drugs | 1971 | https://conductscience.org/library/papers/4932744 | PubMed |
| 18 | 5,026,376 | Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline. | Clin Pharmacol Ther | 1972 | https://conductscience.org/library/papers/5026376 | PubMed |
| 19 | 4,720,690 | A re-evaluation of parenteral aminophylline. | Am Rev Respir Dis | 1973 | https://conductscience.org/library/papers/4720690 | PubMed |
| 20 | 4,723,589 | Rational intravenous doses of theophylline. | N Engl J Med | 1973 | https://conductscience.org/library/papers/4723589 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 25,786,880 | Concurrent oral and inhalation drug delivery using a dual formulation system: the use of oral theophylline carrier with combined inhalable budesonide and terbutaline. | Drug Deliv Transl Res | 2014 | https://conductscience.org/library/papers/25786880 | PubMed |
| 12,519,617 | Oral theophylline for chronic obstructive pulmonary disease. | Cochrane Database Syst Rev | 2002 | https://conductscience.org/library/papers/12519617 | PubMed |
| 7,437,244 | Serum level monitoring of a new slow release theophylline formulation in patients with chronic lung disease. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7437244 | PubMed |
| 7,378,251 | Combination of aminophylline (Phyllocontin Continus tablets) and salbutamol in the management of chronic obstructive airways disease. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7378251 | PubMed |
| 7,213,523 | Theophylline-salbutamol interaction: bronchodilator response to salbutamol at maximally effective plasma theophylline concentrations. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7213523 | PubMed |
| 7,117,350 | The influence of theophylline on maximal response to salbutamol in severe chronic obstructive pulmonary disease. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7117350 | PubMed |
| 7,011,349 | The metabolic actions of intravenous salbutamol and aminophylline singly and in combination. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7011349 | PubMed |
| 6,129,123 | Combination bronchodilator therapy. | Drugs | 1982 | https://conductscience.org/library/papers/6129123 | PubMed |
| 3,081,769 | Tracheal relaxation from combinations of xanthines and of a beta 2-receptor agonist and xanthines. | Lung | 1986 | https://conductscience.org/library/papers/3081769 | PubMed |
| 533,582 | Dose-titration comparison of inhaled salbutamol and oral theophylline in asthma. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/533582 | PubMed |
| 391,006 | On the action of combination bronchodilators. | Agents Actions | 1979 | https://conductscience.org/library/papers/391006 | PubMed |
| 354,635 | Clinical pharmacokinetics of theophylline. | Clin Pharmacokinet | 1978 | https://conductscience.org/library/papers/354635 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23134
GET https://conductscience.org/api/papers/v1/23134/authors